文献速递脑血管病

卒中前或卒中后检出心房颤动患者的复发性卒中、死亡及脑出血风险

Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke.
PubMed 文献 · Neurology · 2025-02-25

该系统综述与荟萃分析比较了卒中后检出心房颤动(AFDAS)与已知心房颤动(KAF)患者的复发性缺血性卒中、脑出血和死亡风险。共纳入17项研究(n=113,365),AFDAS组复发性缺血性卒中(RR=0.79,95%CI 0.66-0.95)和死亡(RR=0.84,95%CI 0.74-0.95)风险显著低于KAF组,脑出血风险相似(RR=0.97,95%CI 0.68-1.39)。

要点

  • AFDAS患者复发性缺血性卒中风险显著低于KAF患者(RR=0.79,95%CI 0.66-0.95)。
  • AFDAS患者死亡风险显著低于KAF患者(RR=0.84,95%CI 0.74-0.95)。
  • AFDAS与KAF的脑出血风险相似(RR=0.97,95%CI 0.68-1.39)。

核心结论

  • 与KAF相比,AFDAS可能具有更低的缺血性卒中复发和死亡风险,且脑出血风险相似。
  • 通过实施心房颤动负荷测量进行分层可能有助于为AFDAS患者提供更个性化的管理。

研究设计与样本

  • 系统综述与荟萃分析,方案注册于PROSPERO(CRD42024583064),遵循PRISMA和MOOSE指南。
  • 检索MEDLINE、EMBASE、Cochrane CENTRAL和MedRxiv至2024年8月28日,纳入比较AFDAS与KAF的队列研究、观察性研究(前瞻性或回顾性)和随机对照试验,排除每组少于15例患者的研究。
  • 共纳入17项研究(n=113,365;nKAF=80,339;nAFDAS=33,026;KAF组女性49.0%;AFDAS组女性45.1%),其中8项为低偏倚风险。
  • 采用随机效应荟萃分析合并风险比(RR),并进行预设敏感性分析(研究质量、AF搜索时机、倾向评分匹配、数据来源)和荟萃回归分析(性别、心血管危险因素、抗凝状态)。

主要发现

  • AFDAS组复发性缺血性卒中风险显著低于KAF组(RR=0.79,95%CI 0.66-0.95,I²=70%;nstudies=10)。
  • 荟萃回归分析显示抗凝、CHA2DS2-VASc评分或性别对两组复发性缺血性卒中风险差异无交互作用。
  • AFDAS组死亡风险低于KAF组(RR=0.84,95%CI 0.74-0.95,I²=74%;nstudies=14)。
  • AFDAS与KAF的脑出血发生率相似(RR=0.97,95%CI 0.68-1.39,I²=58%;nstudies=5)。
  • AFDAS与KAF的任何卒中复发率相似(RR=0.99,95%CI 0.75-1.30;I²=60;nstudies=3)。

关键数值与推荐

  • 复发性缺血性卒中:AFDAS vs KAF的RR=0.79(95%CI 0.66-0.95),I²=70%,nstudies=10。
  • 死亡:AFDAS vs KAF的RR=0.84(95%CI 0.74-0.95),I²=74%,nstudies=14。
  • 脑出血:AFDAS vs KAF的RR=0.97(95%CI 0.68-1.39),I²=58%,nstudies=5。
  • 任何卒中复发:AFDAS vs KAF的RR=0.99(95%CI 0.75-1.30),I²=60%,nstudies=3。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 复发性缺血性卒中分析异质性I²=70%。
  • 死亡分析异质性I²=74%。
  • 脑出血分析异质性I²=58%。
  • 任何卒中复发分析异质性I²=60。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The risk of recurrent ischemic stroke, intracranial hemorrhage, and mortality in people with atrial fibrillation detected after stroke (AFDAS) is still unclear compared with people with known atrial fibrillation (KAF). We systematically reviewed the literature to provide updated estimates for the risk of recurrent stroke, intracerebral hemorrhage, and mortality in AFDAS compared with KAF. METHODS: Our protocol was registered in PROSPERO (CRD42024583064). Presentation followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-Analysis of Observational Studies in Epidemiology guidelines. We searched MEDLINE, EMBASE, Cochrane CENTRAL, and MedRxiv up to August 28, 2024, for studies comparing AFDAS and KAF for the following outcomes of interest: recurrent ischemic stroke (primary), intracerebral hemorrhage, mortality, and any stroke recurrence. We included cohort, observational studies (either prospective or retrospective) and randomized controlled trials and excluded studies with less than 15 patients per group. Eligible studies were assessed for bias using the Risk of Bias in Non-Randomized Studies tool. We pooled study-level results through random-effect meta-analysis of risk ratios (RRs). We also performed prespecified sensitivity analysis for study quality, timing of search for AF, propensity score matching, and study data source (administrative vs local data), and we planned meta-regression analysis to test for the interaction of sex, comorbid cardiovascular risk factors, and anticoagulation status on the difference between AFDAS and KAF. RESULTS: Seventeen studies were retrieved (n = 113,365; nKAF = 80,339; nAFDAS = 33,026; female in KAF, 49.0%; female in AFDAS, 45.1%), eight of which had low risk of bias. Ischemic stroke recurrence was significantly lower in AFDAS compared with the KAF group (RR = 0.79, 95% CI = 0.66-0.95, I2 = 70%; nstudies = 10). Meta-regression analysis revealed no interaction of anticoagulation, CHA2DS2-VASc score, or sex on the difference in risk of recurrent ischemic stroke between groups. Mortality was lower in the AFDAS group compared with KAF (RR = 0.84, 95% CI = 0.74-0.95, I2 = 74%; nstudies = 14). The rates of any intracerebral bleeding (RR = 0.97, 95% CI = 0.68-1.39, I2 = 58%; nstudies = 5) and any stroke recurrence (RR = 0.99, 95% CI = 0.75-1.30; I2 = 60; nstudies = 3) were similar in AFDAS and KAF. DISCUSSION: AFDAS may carry a lower risk of ischemic stroke recurrence and mortality compared with KAF, with similar risk of intracerebral hemorrhage. Stratification through implementation of AF burden measures may support more personalized management for people with AFDAS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Romoli M, Urbinati G, Tudisco V, et al. Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke. Neurology. 2025. PMID: 39999395. doi:10.1212/WNL.0000000000213426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。